Andrew Guggenhime - Sep 2, 2025 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
PRESIDENT AND CFO
Signature
Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact
Stock symbol
PCVX
Transactions as of
Sep 2, 2025
Transactions value $
-$160,325
Form type
4
Date filed
9/4/2025, 04:10 PM
Previous filing
Apr 9, 2025
Next filing
Sep 10, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
GUGGENHIME ANDREW PRESIDENT AND CFO C/O VAXCYTE, INC., 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS Andrew Guggenhime, by /s/ Peter N. Efremenko, Attorney-In-Fact 2025-09-04 0001230724

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -$40.1K -1.27K -0.96% $31.56 131K Sep 2, 2025 Direct F1, F2
transaction PCVX Common Stock Tax liability -$75.1K -2.38K -1.82% $31.56 129K Sep 2, 2025 Direct F1
transaction PCVX Common Stock Tax liability -$45.1K -1.43K -1.11% $31.56 127K Sep 2, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.
F2 Includes 329 shares acquired under the Issuer's Employee Stock Purchase Plan on May 16, 2025.